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Abstract 
Multiple Sclerosis (MS) is an inflammatory demyelinating autoimmune disease of the central 
nervous system. We investigated the association of two missense variants of the MTHFR 
gene, i.e. MTHFR c.677C>T (p.A222V) and c.1298A>C (p.E429A), in 138 patients with 
clinically definite multiple sclerosis (MS) of relapsing remitting course and 138 age- and 
gender-matched healthy controls. No significant differences were found in the frequency of 
the MTHFR c.677C>T polymorphism between MS patients and healthy controls. However, 
the genotype frequencies of the missense variant MTHFR c.1298A>C were significantly 
different between patients (AA/AC/CC: 0.34/0.55/0.11) and controls (0.52/0.36/0.12; 
Pearson’s 2=11.1; p=0.004). These results suggest that homozygosity for the A allele of 
MTHFR c.1298A>C may be protective against the incidence of MS. If confirmed in an 
independent study sample, the underlying mechanisms should be investigated, which may 
lead to novel insights in biochemical factors influencing the aetiology and pathophysiology of 
MS. 
Introduction 
Multiple Sclerosis is an inflammatory demyelinating autoimmune disease of the central 
nervous system (CNS). The current concept of disease aetiology involves both exogenous 
factors and genetically determined dispositions that may favour an imbalance between pro-
inflammatory and anti-inflammatory signals. A strong association between both onset and 
disease course has already been shown for polymorphisms in the HLA system (3) (4). 
Moreover, a number of studies suggested functional relevant polymorphisms in genes 
encoding for immunoregulatory molecules such as IL-6, IL-7, CTLA-4, MMP-9, and CCR-2 
(5-9). 
The enzyme methylenetetrahydrofolate reductase (MTHFR) reduces 5,10-
methylenetetrahydrofolate (5,10-MTHF) to 5-methyltetrahydrofolate (5-MTHF). In 
homocysteine metabolism, 5-MTHF is necessary to remethylate the neurotoxic intermediate 
homocysteine to methionine, which itself serves as precursor of S-adenosylmethionine (SAM) 
essential for CNS myelination (Surtees et al., 1991). Moreover, the substrate of MTHFR, 
5,10-MTHF, is necessary for nucleic acid synthesis. As MTHFR function is important for 
homocysteine metabolism, SAM-synthesis and nucleic acid synthesis, functional genetic 
variants which influence MTHFR activity are attractive candidates for genetic dispositions for 
diseases which involve myelin pathology. Here, we report that the genotype of the missense 
variant MTHFR c.1298A>C (E429A) was associated with multiple sclerosis in a German 
cross-sectional study.  
 
Subjects and Methods 
138 patients with clinically definite MS of relapsing-remitting course according to the Mc 
Donald criteria (23) participating in this study were recruited from the Department of 
Neurology, University of Bonn (101 female, mean age ± 1 standard deviation: 31.5±8,7). 
Additionally, we analyzed 138 age- and gender-matched healthy local controls without 
apparent signs or a history of neurological or immunological disease (101 female, mean age 
30.5±7.3).  
DNA was prepared from peripheral leukocytes. The MTHFR c.677C>T and c.1298A>C 
genotypes were analyzed by PCR amplification with subsequent endonuclease restriction 
analysis as published (Frosst et al., 1991; van der Put et al., 1995).   
For statistical analysis, gender and genotype frequencies (two degrees of freedom) were 
compared between patients and controls using the Pearson’s Chi2 test. The Hardy-Weinberg 
disequilibrium was tested by a Chi2 goodness-of-fit test. Age at onset of the patients was 
compared with age at the time of blood withdrawal of the controls using univariate analysis of 
variance (ANOVA). Age of onset in dependency on the genotype was analyzed by ANOVA. 
The results of these univariate analyses were retested in regression analysis with age and 
gender as covariables and simultaneous analysis of both MTHFR variants: for multiple 
sclerosis (yes or no/ patient or control) as dependent variable, binary regression analysis 
(forward Wald) was used, and for age of onset, linear regression analysis was used (SPSS 
15.0). This study was approved by the local ethics committee. All subjects gave informed 
written consent for DNA analysis. 
 
Results 
The groups of patients and controls did not significantly differ concerning gender (2=0.236; 
p=0.627) or age (F=0.88; p=0.350). There was no significant Hardy-Weinberg-disequilibrium 
concerning the MTHFR genotypes in the patients and in the controls. The frequencies of the 
MTHFR c.1298A>C genotypes in the patient group versus the control group were 
significantly different between patients (AA/AC/CC: 0.34/0.55/0.11) and controls 
(0.52/0.36/0.12; Pearson’s 2=11.1; p=0.004; table 1). Multivariate binary regression analysis 
confirmed the significant prediction of diagnosis by the MTHFR c.1298A>C variant 
(Wald=4.4; p=0.035), whereas c.677C>T, age and gender revealed no significant results (not 
shown). The age of disease onset was not significantly associated with MTHFR c.677C>T or 
c.1298A>C (table 2).  
 
Discussion 
The aetiology of multiple sclerosis is not completely understood. Besides relevant 
immunological factors, epidemiologic studies suggest an influence of yet unidentified genetic 
factors. Within this case-control study, we observed an association of the MTHFR 
c.1298A>C polymorphism with the incidence of multiple sclerosis. Within the limit of any 
case-control study, these data raise the question whether folate and homocysteine metabolism 
may have an impact on the pathogenesis of multiple sclerosis. 
MTHFR converts 5,10-methylenetetrahydrofolate (5,10-MTHF) to 5-methyltetrahydrofolate 
(5-MTHF). 5,10-MTHF is necessary for nucleic acid synthesis, whereas 5-MTHF functions as 
cofactor in the remethylation of methionine from homocysteine. The C-allele of MTHFR 
c.1298A>C is associated with reduced MTHFR activity putatively resulting in higher 
availability of 5,10-MTHF for nucleic acid synthesis and thus for cell proliferation under 
inflammatory conditions (Linnebank M, Linnebank A, Jeub M, et al. Lack of genetic dispositions to hyperhomocysteinemia in 
Alzheimer disease. AmJMedGenetA. 2004;131:101-102.). In addition, reduced MTHFR activity can lower the 
synthesis of methionine by 5-MTHF-dependent methionine synthase leading to decreased 
availability of “active” methionine, i.e. SAM. As SAM has anti-inflammatory properties and 
is necessary for CNS (re)myelination (Surtees et al., 1991), a reduced availability of SAM due 
to reduced MTHFR activity represents one putative pathophysiological explanation for the 
association of the C-allele of MTHFR c.1298A>C with MS as observed in our study.  
Interestingly, the second MTHFR variant investigated, c.677C>T, is known to reduce 
MTHFR activity in cultured fibroblasts and in peripheral lymphocytes to a larger extent than 
c.1298A>C does, but MTHFR c.677C>T was not associated with multiple sclerosis in our 
study population, which argues against the hypothesis that reduced MTHFR activity in 
general is a risk factor for multiple sclerosis. However, we have previously reported data 
suggesting that the variant c.1298A>C may influence neurodegenerative diseases 
independently from MTHFR c.677C>T (Linnebank M, Linnebank A, Jeub M, et al. Lack of genetic dispositions to 
hyperhomocysteinemia in Alzheimer disease. AmJMedGenetA. 2004;131:101-102; Wullner U, Kolsch H, Linnebank M. 
Methylenetetrahydrofolate reductase in Parkinson's disease. AnnNeurol. 2005;58:972-973). The MTHFR variants 
c.1298A>C and c.677C>T are in linkage disequilibrium (Linnebank M, Homberger A, Nowak-Gottl U, 
Marquardt T, Harms E, Koch HG. Linkage disequilibrium of the common mutations 677C > T and 1298A > C of the human 
methylenetetrahydrofolate reductase gene as proven by the novel polymorphisms 129C > T, 1068C > T. EurJPediatr. 2000;159:472-473). 
However, the limited size of our study sample precluded the analysis of an association of 
MTHFR c.677C>T; c.1298A>C haplotypes with MS.  
In summary, within the limits of any association study, the present study reports an 
association of the C-allele of MTHFR c.1298A>C with the incidence of multiple sclerosis. As 
MTHFR is involved in folate and methionine metabolism, and reduced MTHFR activity can 
at least partly be overcome by vitamin or amino acid supplementation, the association of an 
MTHFR variant with increased MS incidence represents a novel aspect in the whole range of 
pathophysiological components contributing to MS that can be targeted by dietary 
supplementation. Thus, if validated in an independent and larger study sample, these data 
could be clinically relevant.  
  
 
Table 1. Frequency of MTHFR genotypes in patients and controls.  
MTHFR c.677 C>T CC CT TT Pearson’s 
2;p 
patients (n=143) 0.54 0.39 0.07 
controls (n=142) 0.52 0.39 0.08 
0.24; 0.888 
 
MTHFR 
c.1298A>C 
AA AC CC Pearson’s 
2;p 
patients (n=145) 0.34 0.55 0.11 
controls (n=145) 0.53 0.35 0.12 
12.7; 0.002 
 
Concerning MTHFR c.677C>T, genotyping did not succeed for 2 patient and 3 control 
samples. 
Table 2. MTHFR genotypes and age of onset 
MTHFR c.677 C>T CC CT TT ANOVA: F; 
p 
age of onset 30.6±8.6 32.0±8.4 34.8±11.3 0.93; 0.398 
 
MTHFR 
c.1298A>C 
AA AC CC ANOVA: F; 
p 
age of onset 30.9±7.6 31.7±9.6 32.2±6.4 0.15; 0.866 
 
Age of onset ± 1 standard deviation in the multiple sclerosis patients. Linear regression 
analysis with both genotypes and gender as covariables and age of onset as dependent 
variable did not reveal significant results, either (not shown).  
 
 
